The novel vasopressin receptor (V1aR) antagonist SRX246 reduces anxiety in an experimental model in humans: a randomized proof-of-concept study

Authors: Tiffany R. Lago, Michael Brownstein, Emily Page, Emily Beydler, Adrienne Manbeck, Alexis Beale, Camille Roberts, Nicholas L. Balderston, Eve Damiano, Suzanne L. Pineles, Neal G. Simon, Monique Ernst, Christian Grillon - Psychopharmacology 2021 cited by 36